Literature DB >> 18977369

Asymmetric division of activated latently infected cells may explain the decay kinetics of the HIV-1 latent reservoir and intermittent viral blips.

Libin Rong1, Alan S Perelson.   

Abstract

Most HIV-infected patients when treated with combination antiretroviral therapy achieve viral loads that are below the current limit of detection of standard assays after a few months. Despite this, virus eradication from the host has not been achieved. Latent, replication-competent HIV-1 can generally be identified in resting memory CD4(+) T cells in patients with "undetectable" viral loads. Turnover of these cells is extremely slow but virus can be released from the latent reservoir quickly upon cessation of therapy. In addition, a number of patients experience transient episodes of viremia, or HIV-1 blips, even with suppression of the viral load to below the limit of detection for many years. The mechanisms underlying the slow decay of the latent reservoir and the occurrence of intermittent viral blips have not been fully elucidated. In this study, we address these two issues by developing a mathematical model that explores a hypothesis about latently infected cell activation. We propose that asymmetric division of latently infected cells upon sporadic antigen encounter may both replenish the latent reservoir and generate intermittent viral blips. Interestingly, we show that occasional replenishment of the latent reservoir induced by reactivation of latently infected cells may reconcile the differences between the divergent estimates of the half-life of the latent reservoir in the literature.

Entities:  

Mesh:

Year:  2008        PMID: 18977369      PMCID: PMC2657607          DOI: 10.1016/j.mbs.2008.10.006

Source DB:  PubMed          Journal:  Math Biosci        ISSN: 0025-5564            Impact factor:   2.144


  79 in total

1.  Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

Authors:  Janet D Siliciano; Joleen Kajdas; Diana Finzi; Thomas C Quinn; Karen Chadwick; Joseph B Margolick; Colin Kovacs; Stephen J Gange; Robert F Siliciano
Journal:  Nat Med       Date:  2003-05-18       Impact factor: 53.440

2.  Memory T and memory B cells share a transcriptional program of self-renewal with long-term hematopoietic stem cells.

Authors:  Chance John Luckey; Deepta Bhattacharya; Ananda W Goldrath; Irving L Weissman; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

3.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

Authors:  T W Chun; L Stuyver; S B Mizell; L A Ehler; J A Mican; M Baseler; A L Lloyd; M A Nowak; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

4.  Human immunodeficiency virus drug therapy and virus load.

Authors:  S Bonhoeffer; J M Coffin; M A Nowak
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

5.  Productive infection maintains a dynamic steady state of residual viremia in human immunodeficiency virus type 1-infected persons treated with suppressive antiretroviral therapy for five years.

Authors:  Diane V Havlir; Matthew C Strain; Mario Clerici; Caroline Ignacio; Daria Trabattoni; Pasquale Ferrante; Joseph K Wong
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

6.  Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis.

Authors:  M Bofill; G Janossy; C A Lee; D MacDonald-Burns; A N Phillips; C Sabin; A Timms; M A Johnson; P B Kernoff
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

7.  Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group.

Authors:  A C Collier; R W Coombs; D A Schoenfeld; R L Bassett; J Timpone; A Baruch; M Jones; K Facey; C Whitacre; V J McAuliffe; H M Friedman; T C Merigan; R C Reichman; C Hooper; L Corey
Journal:  N Engl J Med       Date:  1996-04-18       Impact factor: 91.245

8.  Viral and latent reservoir persistence in HIV-1-infected patients on therapy.

Authors:  Hwijin Kim; Alan S Perelson
Journal:  PLoS Comput Biol       Date:  2006-08-28       Impact factor: 4.475

9.  Limits on replenishment of the resting CD4+ T cell reservoir for HIV in patients on HAART.

Authors:  Ahmad R Sedaghat; Janet D Siliciano; Timothy P Brennan; Claus O Wilke; Robert F Siliciano
Journal:  PLoS Pathog       Date:  2007-08-31       Impact factor: 6.823

10.  (A)symmetric stem cell replication and cancer.

Authors:  David Dingli; Arne Traulsen; Franziska Michor; Fransizka Michor
Journal:  PLoS Comput Biol       Date:  2007-02-01       Impact factor: 4.475

View more
  26 in total

1.  Monitoring of HIV type 1 DNA load and drug resistance in peripheral blood mononuclear cells during suppressive antiretroviral therapy does not predict virologic failure.

Authors:  Ingrid A Beck; Minyoung Jang; Jennifer McKernan-Mullin; Marta Bull; Thor Wagner; Sharon Huang; Lin-Ye Song; Sharon Nachman; Paul Krogstad; Susan H Eshleman; Andrew Wiznia; Lisa M Frenkel
Journal:  AIDS Res Hum Retroviruses       Date:  2012-01-27       Impact factor: 2.205

2.  Post-treatment control of HIV infection.

Authors:  Jessica M Conway; Alan S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

3.  Contribution of follicular dendritic cells to persistent HIV viremia.

Authors:  Jingshan Zhang; Alan S Perelson
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

4.  Resistance evolution in HIV - modeling when to intervene.

Authors:  Liliana Mabel Peinado Cortes; Ryan Zurakowski
Journal:  Proc Am Control Conf       Date:  2012

5.  Backward bifurcations, turning points and rich dynamics in simple disease models.

Authors:  Wenjing Zhang; Lindi M Wahl; Pei Yu
Journal:  J Math Biol       Date:  2016-02-26       Impact factor: 2.259

Review 6.  Human systems immunology: hypothesis-based modeling and unbiased data-driven approaches.

Authors:  Arnon Arazi; William F Pendergraft; Ruy M Ribeiro; Alan S Perelson; Nir Hacohen
Journal:  Semin Immunol       Date:  2013-01-29       Impact factor: 11.130

Review 7.  Mathematical Models of HIV Latency.

Authors:  Alison L Hill
Journal:  Curr Top Microbiol Immunol       Date:  2018       Impact factor: 4.291

Review 8.  Modeling HIV persistence, the latent reservoir, and viral blips.

Authors:  Libin Rong; Alan S Perelson
Journal:  J Theor Biol       Date:  2009-06-17       Impact factor: 2.691

9.  Quantifying the treatment efficacy of reverse transcriptase inhibitors: new analyses of clinical data based on within-host modeling.

Authors:  Romulus Breban; Sonia Napravnik; James Kahn; Sally Blower
Journal:  BMC Public Health       Date:  2009-11-18       Impact factor: 3.295

10.  Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy.

Authors:  Libin Rong; Alan S Perelson
Journal:  PLoS Comput Biol       Date:  2009-10-16       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.